Clarivate Files Pro Forma Financials for $600M LS&H Divestiture
CLVT is trading near its 52-week low of $1.42 (13% above the low).
Summary
Clarivate filed pro forma financials for its completed $600M LS&H divestiture, showing a leaner continuing business with $488.4M net cash proceeds applied to debt reduction.
Key Events · M&A and Partnerships · CLVT
-
Pro Forma Financials Filed
8-K/A provides unaudited pro forma balance sheet as of June 30, 2026 and statements of operations for 2023-2025 and H1 2026, reflecting LS&H as discontinued operations.
-
Net Proceeds Below Headline
Actual cash received at close was $488.4M, not $500M, after closing costs and working capital adjustments; plus a $75M unsecured senior note and $25M deferred cash consideration.
-
Debt Reduction Deployment
$488.4M of sale proceeds plus $11.6M of company cash applied to partial redemptions of 2028 and 2029 senior notes, plus a $75M tender offer for 2028 notes; pro forma long-term debt falls from $4.21B to $3.63B.
-
Continuing Operations Profile
Pro forma H1 2026 revenue of $990.8M (vs. $1,172.8M historical) with operating income of $41.4M (vs. -$170.0M historical), as the $221.7M LS&H goodwill impairment is eliminated.
Analysis · CLVT · Technology
This 8-K/A delivers the required pro forma financials for the completed Life Sciences & Healthcare sale, quantifying the deal's impact on continuing operations. The pro forma statements show Clarivate's remaining business generated $990.8M in revenue for H1 2026 with operating income of $41.4M — a dramatic swing from the $170.0M operating loss reported historically, largely because the $221.7M goodwill impairment tied to LS&H is eliminated. Net cash received was $488.4M, not the $500M headline figure, after closing costs and working capital adjustments. The proceeds were largely deployed to debt reduction: $488.4M of sale cash plus $11.6M of company cash went toward partial redemptions of 2028 and 2029 senior notes, alongside a $75M tender offer for 2028 notes. This materially de-risks the balance sheet — long-term debt drops from $4.21B to $3.63B on a pro forma basis — while the remaining company is smaller but more focused.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CLVT was trading at $1.60 on NYSE in the Technology sector, with a market capitalization of approximately $1B. The 52-week trading range was $1.42 to $3.87. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.